| Literature DB >> 28144487 |
David Altschul1, Arundhati Biswas1, Jonathan Nakhla1, Murray Echt1, David Gordon1.
Abstract
BACKGROUND: Onyx has improved the safety and efficacy of endovascular treatment in the management of cerebral arteriovenous malformations (AVMs). However, during injection inadvertent reflux around the delivery microcatheter into important normal arterial branches remains a major challenge.Entities:
Keywords: Cerebral arteriovenous malformations; Endovascular treatment; Onyx; embolization
Year: 2016 PMID: 28144487 PMCID: PMC5234298 DOI: 10.4103/2152-7806.196380
Source DB: PubMed Journal: Surg Neurol Int ISSN: 2152-7806
Figure 1(a) Digital subtraction angiography prior to staged embolization with right internal carotid artery selective injection demonstrating arteriovenous malformation (AVM) (b) Double microcatheter technique with superselective injection ensuring that Onyx will not enter en-passage arteries; black arrowhead points to the detachment zone of the Echelon microcatheter with contrast injection, white arrowhead points to the coil detachment of the Echelon microcatheter, and the arrow points to the detachment tip of the Apollo microcatheter (c) Onyx within nidus of AVM after detachment of Apollo. (d) Control angiogram shows reduction in AVM opacification